Italy Classifies CBD Oil as a Narcotic, Threatening Industry

The Italian Ministry of Health recently surprised the country’s hemp industry by lifting the suspension on a controversial decree originally issued in October 2020. This decree aimed to classify oral CBD extracts as narcotics.

Specifically, the decree stated that “compositions for oral administration of cannabidiol obtained from extracts of Cannabis” would be included in the table of medicinal drugs and categorized as a restricted narcotic.

The revocation of the suspension will take effect 30 days after publication in the Official Gazette, on September 21, 2023. After this date, the sale of cannabidiol in the form of oils and other extracts will only be allowed in pharmacies and under medical supervision.

What Does This Mean for CBD Oil in Italy?

If fully implemented, Italy could become the only country in Europe to consider oral CBD preparations as narcotics. The repeal will impact existing and future CBD products on the Italian market. CBD oils may disappear from general retail, unless prepared with synthetic CBD not covered by the provision. The future of cannabis light products high in CBD is also uncertain.

However, the European Court of Justice has ruled that CBD products in EU member states should not be considered narcotics and should be allowed to move freely.

Attorney Carlo Alberto Zaina told DolceVitaOnline the importance of a collective action that could contest the decree within 60 days of its publication in the official journal.

“When an entire sector sees its business freedom rights trampled, it is necessary to present a united front and take the necessary legal actions before the appropriate bodies, in order to safeguard the countless companies tied to the industry and all the jobs that ensue,” Zaina stated.

The lawyer, who has contested the Speranza decree of 2020 multiple times, stresses that behind wording meant to dissuade anyone from reading the decree’s content, nothing is hidden.

“It is certain,” Zaina continues, “that the only way to oppose this unacceptable drift is to lead a new uncompromising jurisdictional legal battle, to which all the affected activities can join, the very existence of which depends on it.”

What Comes Next?

The hemp industry will likely unite and pursue legal action to fight the classification. CBD companies and advocates argue the decree violates EU policy on free movement of goods.

Italy has a significant medical cannabis program, although access has been hampered by supply issues. Further restricting CBD access based on this decree could harm patients relying on it for relief.

While the Italian government maintains the classification is necessary to regulate unsafe products, the hemp industry believes it is overreach that will only empower the black market. They hope concerted legal action can block the decree before it takes effect later this month.

The decision has also drawn criticism from consumer advocates concerned that limiting CBD access contradicts public health goals. However, some health professionals argue CBD requires tighter control and oversight.

Italy’s changing stance reflects the general uncertainty around CBD regulation globally. The debate involves patient access, consumer safety, the cannabis industry, and drug policy. Although the World Health Organization has declared CBD is safe and non-addictive, many countries still struggle with appropriate oversight models.

For CBD companies in Italy, the next few weeks will prove critical. Failure to stop the decree’s enactment will force businesses to drastically alter their operations or pursue the unpredictable legal cannabis niche.…

CBD oils

Buying CBD in France: the guide to finding your way around

If you’re new to the world of CBD, making your first purchase can seem daunting. There are so many brands and products on the market today that it can be difficult to find the right product for your needs.

Before buying CBD, and to make sure it is effective, there are many factors to consider such as the type of product, the percentage of CBD, the reliability of the seller, the source of the CBD and, above all, your need.

At Dhpregie we believe that there is a CBD product for every individual. Our guide will help you find yours and advise your loved ones if necessary.

Why buy CBD when in Europe?

CBD is one of 120+ compounds, or cannabinoids, found in the hemp plant (cannabis sativa L). It is the second most abundant cannabinoid after tetrahydrocannabinol (THC). However, unlike THC, CBD is not a psychotropic drug. It is thanks to the isolation of the CBD molecule that it is possible to enjoy the benefits of the plant while avoiding its narcotic effects. It is neither addictive, nor toxic and does not “get high”.

Cannabinoids act in various ways on the body’s endocannabinoid system. This system plays a crucial role in maintaining the various balances of the body. On the scale of the human body, it is for example the management of weight, body temperature, blood sugar, heart rate, digestive system … etc..

In this sense, CBD would have the following properties:

  • anti-inflammatory
  • anticonvulsant
  • analgesic (pain)
  • anxiolytic (anti-anxiety)
  • sedative
  • antipsychotic

American scientific research is advancing rapidly and now proves that CBD has beneficial effects on health. In addition, the French government and the Ministry of Health are committed to starting a medical cannabis trial program. On the other hand, it is currently forbidden to promote the potential beneficial effects of CBD until the information has been officially ruled by the State.

There appear to be very few adverse side effects, and most people tolerate it well. CBD is not abused or addictive, as long as people don’t mix it with other potentially toxic substances.

CBD is increasingly used around the world to help relieve stress and anxiety, manage pain and induce a sense of well-being, among other things.

Is buying CBD legal in France?


Buying CBD in France is legal, but the legislation is still vague. It authorizes the purchase of CBD provided that the CBD product is derived from a hemp plant with a THC content of less than 0.2%. Be careful to select a reliable brand working with producers who implement controls.

What types of CBD products to buy?

Choosing the right product is important because each ingestion method has a different level of effectiveness, therapeutic properties, onset and duration. Below are the most popular product categories currently available.

oil made of cannabidiol sold in France

CBD oils

CBD oils are by far the most popular products available today. Oils trump all other types of CBD products when it comes to dosing accuracy. In fact, all oils come with a precise dropper that makes it easy to increase or decrease doses.

The oil is the fastest method of absorption. It is absorbed sublingually (under the tongue), which means it works faster than most other forms of CBD products.

When starting out, buying oil may be the right method to be able to go gradually and know your ideal dosage. Visit this partner website to find the best CBD oils in France

Choosing the right spectrum

One of the first things you’ll see about CBD oils is their “spectrum.”

The spectrum actually represents the concentration of cannabinoids present in the extract.

Full spectrum CBD oils contain a wide variety of cannabinoids and terpenes from the original hemp plant. These products are known to offer maximum therapeutic benefits because they contain the widest variety of compounds available and take advantage of the entourage effect: that is, the potency of all the components added together. Moreover, they also contain a tiny dose of THC, but this one does not have psychotropic effects and is normally undetectable since it is lower than 0,2%.

Oils with broad spectrum

The CBD isolate oils (isolate) contain only CBD without THC and other cannabinoids. These are not recommended because they do not take advantage of the surrounding effect of the hemp plant. On the other hand, they should be preferred by people who are sensitive or even intolerant to THC.

To summarize: if you wish to benefit from the therapeutic effects of CBD you must privilege the purchase of oil with broad spectrum or complete for their strong concentrations in cannabinoids.

CBD flowers

Flowers are one of the purest and most natural forms of CBD consumption. They will be ideal if you are already a smoker and you are nostalgic of the gesture or the effect of cannabis for example. CBD can be a good way to reduce its consumption.

Be careful though, CBD does not give you the high of cannabis, it is a different effect and the collateral effects of the substances that will accompany your intake such as tobacco for example can be bad.

Like oils, when you inhale CBD and other cannabis compounds, the effect comes on quickly, but it will last less time.

Our plants, from seeds registered in the EU catalog of seeds and varieties, produce CBD flowers that do not contain THC (<0.2%) and are thus authorized in France and in Europe.…

cannamoms tendance

“Cannamoms”: mothers who swear by cannabis

More and more women are using microdoses of cannabis to relax. They believe it helps them to be more available mothers to their children, reports the BBC website.

What if using cannabis helps you be a better parent? According to the BBC, more and more women are defining themselves as “cannamoms” and defending this point of view.

An American journalist started the trend

This is the case of Danielle Simone Brand, an American journalist who got into it in 2016, when California legalized consumption for adults. This mother of two children aged 8 and 11 even made a book about it, published in December 2020, Weed Mom: The Canna-Curious Woman’s Guide to Healthier Relaxation, Happier Parenting, and Chilling TF Out (“Maman Beuh: le guide de la femme canna-curieuse pour une relaxation plus saine, une parentalité plus heureuse et pour une p* de détente”).

In it, Brand explains that cannabis helps her not to be overwhelmed by the mental load of daily tasks and to have more patience and availability for her children.

This phenomenon is actually not new, but it seems to be growing judging by the number of “cannamoms” groups on social networks. Heather McIlvaine-Newsad, a professor of anthropology at Western Illinois University, is part of an interdisciplinary research project on cannabis and culture. She became aware in 2018 of Facebook groups about cannabis and parenting. Some had existed for many years and there are nearly 30 in all, each with thousands of members.

Latrese Thomas, a 40-year-old African-American mother of three, told the BBC that she uses cannabis “the same way others drink wine.” She added that, in the context of racial tensions particularly affecting the black community, cannabis “helped her control [her] anxiety as a mom – and not just as a black woman, but as a mom of black kids.” Many women also explain that their use has helped them cope with the stress of Covid and health measures.

The key: always microdose

The key, they all say, is to microdose. The BBC insists that there are no conclusive scientific studies on the effects of microdosing in the medium or long term, but it is certain that it can affect concentration and disrupt certain motor functions.

Precisely, all the consumers interviewed by the BBC mention the frowns they observe when they talk about their lifestyle. Latrese Thomas is aware of this and is careful who she talks to about it, especially since she is black, she points out. Heather McIlvaine-Newsad sums it up this way:

“It’s socially acceptable for a mother to say ‘Mommy needs a little glass of wine,’ but it’s still not acceptable to say ‘Mommy needs a microdose of cannabis.'”

Nevertheless, mentalities seem to be changing, especially with the arrival of a generation that has seen its parents but also its grandparents take cannabis. The “cannamoms” would thus have beautiful days before them.…

US teens are not using more cannabis as states legalize

US teens are not using more cannabis as states legalize

Cannabis use among American youth fell in 2020 as a result of the coronavirus pandemic and the increase in the number of states adopting legalization, according to a newly released U.S. federal survey.

As a result, past-year cannabis use among 12- to 17-year-olds dropped from 13.2 percent to 10.1 percent between 2019 and 2020, according to the survey conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA). Among 18- to 25-year-olds, over-the-year use also dropped from 35.4 percent to 34.5 percent from the previous year.

Use among adults 26 and older, however, has trended upward in recent years.

For this survey, researchers noted that the methodology was modified due to the COVID-19 pandemic. For example, interviews were conducted virtually, rather than in person, for safety reasons. Because of this change, “caution should be used when comparing estimates,” they said.

Accumulating data

Numerous studies were now that cannabis legalization does not lead to an increase in youth use.

For example, a study published by the Journal of the American Medical Association in September found that rates of cannabis use among teens do not increase after legalizations for medical or recreational purposes.

National Institute on Drug Abuse (NIDA) Director Nora Volkow also admitted in a recent interview that legalization has not led to an increase in youth use, despite her earlier fears.

In a separate, earlier analysis, the Centers for Disease Control and Prevention found that marijuana use among high school students declined during the peak years of state legalization of recreational cannabis.

According to the survey, there was “no change” in the rate of current cannabis use among high school students between 2009 and 2019. However, when analyzed using a quadratic change model, lifetime marijuana use decreased during that time.

Another study released by Colorado officials last year found that youth cannabis use in the state “has not changed significantly since legalization” in 2012, although methods of use are diversifying.

In Canada, cannabis use among 15- to 17-year-olds has dropped 47% since legalization…

New York approves self-cultivation for medical cannabis patients

New York approves self-cultivation for medical cannabis patients

Medical cannabis patients in New York will soon be allowed to grow their own cannabis under new rules decided at the second meeting of the Cannabis Control Board (CCB).

Home cultivation had been included in the bill approved by the legislature earlier this year It did, however, include provisions prohibiting home cultivation until retail sales are launched in the state, beginning in 2022.

Under the proposed rules, which still must go through a 60-day public comment period that the BCC can adjust before they go into effect, registered patients will be able to grow up to three immature (growing) and three mature (flowering) plants per individual or up to six immature and six mature plants per household.

Only for certified patients

“Only certified patients or their designated caregivers participating in the medical cannabis program will be able to legally purchase seeds or immature plants from a registered organization,” said Chris Alexander, executive director of the BCC. “And so, New Yorkers who are not participating in the medical program cannot yet cultivate and grow at home.”

Board members also approved the expungement of more than 200,000 criminal records for offenses that are no longer illegal in the state under the Adult Use Act.

CCD Executive Director Chris Alexander said the state was already refusing to conduct background checks on cannabis arrests and that those charges would eventually be expunged.

“When completed, the actions of these measures will have expunged the records of more than 400,000 New Yorkers, a staggering reminder of the impact that cannabis prohibition has had on so many people.” explained Chris Alexander.

As of 2019, the state had expunged some 198,000 cannabis-related criminal records, even before the sweeping legalization reforms.

During its first meeting earlier this month, the board permanently waived fees for medical cannabis patients and caregivers, made flower an approved form of medical cannabis in the state, and approved allowing patients to get a 60-day supply of medical cannabis instead of just a month.

Legal and adult-use sales of cannabis are expected in New York starting in 2022.…